Tea consumption reduces the risk of de novo myelodysplastic syndromes

P. Liu, Min Zhang, J. Jin, D'Arcy Holman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

© 2014 Elsevier Ltd. Epidemiologic data suggest that green tea consumption may protect against certain cancers, but no previous study has examined myelodysplastic syndromes (MDS). A hospital-based case-control study was conducted in China in 2012-2013 to investigate the association between tea intake and the risk of de novo MDS in adults. The study included 208 cases aged 19-85 years with MDS and 208 controls individually matched to the cases by gender, 5-year age group and residential locality. Odds ratios (ORs) were estimated using conditional logistic regression. Compared with non-tea drinkers, the adjusted ORs (95% confidence intervals) for all MDS combined were 0.39 (0.20-0.74), 0.45 (0.25-0.79), and 0.40 (0.21-0.77) for those who consumed tea >20 years, ≥2 cups daily, and dried tealeaves ≥750. g per annum, respectively. Significant dose-response trends were observed across all the measures. The inverse association existed in both genders, in the refractory anemia with excessive blasts subtype, in cytogenetic 'good' and 'intermediated/poor' prognosis groups, and in the International Prognostic Scoring System lower and higher risk groups, but not in the refractory cytopenia with multilineage dysplasia subtype. The study suggests that regular tea consumption reduces the risk of de novo MDS in the Chinese population.
Original languageEnglish
Pages (from-to)164-169
JournalLeukemia Research
Volume39
Issue number2
DOIs
Publication statusPublished - 2015

Fingerprint

Myelodysplastic Syndromes
Tea
Odds Ratio
Refractory Anemia
Cytogenetics
Case-Control Studies
China
Age Groups
Logistic Models
Confidence Intervals
Population
Neoplasms

Cite this

Liu, P. ; Zhang, Min ; Jin, J. ; Holman, D'Arcy. / Tea consumption reduces the risk of de novo myelodysplastic syndromes. In: Leukemia Research. 2015 ; Vol. 39, No. 2. pp. 164-169.
@article{fcfe42d99cfc4d75be0356d090dad56f,
title = "Tea consumption reduces the risk of de novo myelodysplastic syndromes",
abstract = "{\circledC} 2014 Elsevier Ltd. Epidemiologic data suggest that green tea consumption may protect against certain cancers, but no previous study has examined myelodysplastic syndromes (MDS). A hospital-based case-control study was conducted in China in 2012-2013 to investigate the association between tea intake and the risk of de novo MDS in adults. The study included 208 cases aged 19-85 years with MDS and 208 controls individually matched to the cases by gender, 5-year age group and residential locality. Odds ratios (ORs) were estimated using conditional logistic regression. Compared with non-tea drinkers, the adjusted ORs (95{\%} confidence intervals) for all MDS combined were 0.39 (0.20-0.74), 0.45 (0.25-0.79), and 0.40 (0.21-0.77) for those who consumed tea >20 years, ≥2 cups daily, and dried tealeaves ≥750. g per annum, respectively. Significant dose-response trends were observed across all the measures. The inverse association existed in both genders, in the refractory anemia with excessive blasts subtype, in cytogenetic 'good' and 'intermediated/poor' prognosis groups, and in the International Prognostic Scoring System lower and higher risk groups, but not in the refractory cytopenia with multilineage dysplasia subtype. The study suggests that regular tea consumption reduces the risk of de novo MDS in the Chinese population.",
author = "P. Liu and Min Zhang and J. Jin and D'Arcy Holman",
year = "2015",
doi = "10.1016/j.leukres.2014.11.020",
language = "English",
volume = "39",
pages = "164--169",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier",
number = "2",

}

Tea consumption reduces the risk of de novo myelodysplastic syndromes. / Liu, P.; Zhang, Min; Jin, J.; Holman, D'Arcy.

In: Leukemia Research, Vol. 39, No. 2, 2015, p. 164-169.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tea consumption reduces the risk of de novo myelodysplastic syndromes

AU - Liu, P.

AU - Zhang, Min

AU - Jin, J.

AU - Holman, D'Arcy

PY - 2015

Y1 - 2015

N2 - © 2014 Elsevier Ltd. Epidemiologic data suggest that green tea consumption may protect against certain cancers, but no previous study has examined myelodysplastic syndromes (MDS). A hospital-based case-control study was conducted in China in 2012-2013 to investigate the association between tea intake and the risk of de novo MDS in adults. The study included 208 cases aged 19-85 years with MDS and 208 controls individually matched to the cases by gender, 5-year age group and residential locality. Odds ratios (ORs) were estimated using conditional logistic regression. Compared with non-tea drinkers, the adjusted ORs (95% confidence intervals) for all MDS combined were 0.39 (0.20-0.74), 0.45 (0.25-0.79), and 0.40 (0.21-0.77) for those who consumed tea >20 years, ≥2 cups daily, and dried tealeaves ≥750. g per annum, respectively. Significant dose-response trends were observed across all the measures. The inverse association existed in both genders, in the refractory anemia with excessive blasts subtype, in cytogenetic 'good' and 'intermediated/poor' prognosis groups, and in the International Prognostic Scoring System lower and higher risk groups, but not in the refractory cytopenia with multilineage dysplasia subtype. The study suggests that regular tea consumption reduces the risk of de novo MDS in the Chinese population.

AB - © 2014 Elsevier Ltd. Epidemiologic data suggest that green tea consumption may protect against certain cancers, but no previous study has examined myelodysplastic syndromes (MDS). A hospital-based case-control study was conducted in China in 2012-2013 to investigate the association between tea intake and the risk of de novo MDS in adults. The study included 208 cases aged 19-85 years with MDS and 208 controls individually matched to the cases by gender, 5-year age group and residential locality. Odds ratios (ORs) were estimated using conditional logistic regression. Compared with non-tea drinkers, the adjusted ORs (95% confidence intervals) for all MDS combined were 0.39 (0.20-0.74), 0.45 (0.25-0.79), and 0.40 (0.21-0.77) for those who consumed tea >20 years, ≥2 cups daily, and dried tealeaves ≥750. g per annum, respectively. Significant dose-response trends were observed across all the measures. The inverse association existed in both genders, in the refractory anemia with excessive blasts subtype, in cytogenetic 'good' and 'intermediated/poor' prognosis groups, and in the International Prognostic Scoring System lower and higher risk groups, but not in the refractory cytopenia with multilineage dysplasia subtype. The study suggests that regular tea consumption reduces the risk of de novo MDS in the Chinese population.

U2 - 10.1016/j.leukres.2014.11.020

DO - 10.1016/j.leukres.2014.11.020

M3 - Article

VL - 39

SP - 164

EP - 169

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 2

ER -